Quarterly Result2 Nov 2026, 08:11 pm
Sun Pharma Advanced Research Declares Q2 FY27 Financial Results
AI Summary
Sun Pharma Advanced Research Company Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on November 02, 2026. A limited review report from the statutory auditors is also enclosed.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results cover both standalone and consolidated statements.
- Financial period ended September 30, 2026.
- Limited review report from auditors is attached.
Price Impact
More from SPARC